BerGenBio’s Board of Directors is composed of experienced biopharmaceutical executives with experience of developing next generation cancer drugs and building world class innovative oncology biotechnology companies. The Board also represents leading investors and has substantial commercial experience to navigate the development of the Company.
Board of Directors
Dr. Stener Kvinnsland
Non-Executive Director
Stener Kvinnsland has more than 30 years of experience in…
Read More
Dr. Pamela A. Trail
Non-Executive Director
Pamela A. Trail most recently seerved as CSO of Molecular…
Read More
Mr. Grunde Eriksen
Non-Executive Director
Grunde Eriksen is the founder and CEO of Altitude Capital…
Read More
Dr. Debra Barker
Non-Executive Director
Debra Barker is a seasoned clinical development executive with experience…
Read MorePhoto: Nils Olav Mevatne
Jonas Lies vei 91, 5009 Bergen, Norway
+ 47 559 61 159